Combination of anastrozole and fulvestrant extends survival in women with metastatic breast cancer
Results of a SWOG clinical trial published August 2 in the New England Journal of Medicine show the combination of anastrozole and fulvestrant extended the median survival time of women with hormone receptor-positive metastatic breast cancer by more..
Original Article: Combination of anastrozole and fulvestrant extends survival in women with metastatic breast cancer
NEXT ARTICLE